Bisphenol A (BPA), a chemical widely used to manufacture plastics, is estrogenic and capable of disrupting sex differentiation. However, recent in vitro studies have shown that BPA can also antagonize T 3 activation of the T 3 receptor. The difficulty in studying uterus-enclosed mammalian embryos has hampered the analysis on the direct effects of BPA during vertebrate development. This study proposed to identify critical T 3 pathways that may be disrupted by BPA based on molecular analysis in vivo. Because amphibian metamorphosis requires T 3 and encompasses the postembryonic period in mammals when T 3 action is most critical, we used this unique model for studying the effect of BPA on T 3 -dependent vertebrate development at both the morphological and molecular levels. After 4 d of exposure, BPA inhibited T 3 -induced intestinal remodeling in premetamorphic Xenopus laevis tadpoles. Importantly, microarray analysis revealed that BPA antagonized the regulation of most T 3 -response genes, thereby explaining the inhibitory effect of BPA on metamorphosis. Surprisingly, most of the genes affected by BPA in the presence of T 3 were T 3 -response genes, suggesting that BPA predominantly affected T 3 -signaling pathways during metamorphosis. Our finding that this endocrine disruptor, well known for its estrogenic activity in vitro, functions to inhibit T 3 pathways to affect vertebrate development in vivo and thus not only provides a mechanism for the likely deleterious effects of BPA on human development but also demonstrates the importance of studying endocrine disruption in a developmental context in vivo.
Bisphenol A (BPA), a chemical widely used to manufacture plastics, is estrogenic and capable of disrupting sex differentiation. However, recent in vitro studies have shown that BPA can also antagonize T 3 activation of the T 3 receptor. The difficulty in studying uterus-enclosed mammalian embryos has hampered the analysis on the direct effects of BPA during vertebrate development. This study proposed to identify critical T 3 pathways that may be disrupted by BPA based on molecular analysis in vivo. Because amphibian metamorphosis requires T 3 and encompasses the postembryonic period in mammals when T 3 action is most critical, we used this unique model for studying the effect of BPA on T 3 -dependent vertebrate development at both the morphological and molecular levels. After 4 d of exposure, BPA inhibited T 3 -induced intestinal remodeling in premetamorphic Xenopus laevis tadpoles. Importantly, microarray analysis revealed that BPA antagonized the regulation of most T 3 -response genes, thereby explaining the inhibitory effect of BPA on metamorphosis. Surprisingly, most of the genes affected by BPA in the presence of T 3 were T 3 -response genes, suggesting that BPA predominantly affected T 3 -signaling pathways during metamorphosis. Our finding that this endocrine disruptor, well known for its estrogenic activity in vitro, functions to inhibit T 3 pathways to affect vertebrate development in vivo and thus not only provides a mechanism for the likely deleterious effects of BPA on human development but also demonstrates the importance of studying endocrine disruption in a developmental context in vivo. (Endocrinology 150: 2964 -2973, 2009) E ndocrine disruption by environmental contaminants poses a great concern for global ecology and human health. Endocrine disrupting compounds (EDCs) have been defined as exogenous substances that alter function(s) of the endocrine system and consequently cause adverse health effects in an intact organism, or its progeny, or (sub)populations (1) (2) (3) . Some EDCs act as antiestrogenic and antiandrogenic agents to affect reproductive function and sexual development (4) , suggesting that EDCs are responsible for the increased appearance of reproductive health problems in both human and wildlife. In humans, the trend for increased breast and testicular cancers, reduced sperm counts, and early puberty has been attributed to increased exposure to EDCs (5) (6) (7) . In wildlife, decreased species populations and increased animal malformations, including feminization and hermaphroditism, have been reported worldwide (8 -11) . There is also increasing concern that EDCs may affect other endocrine systems, such as the T 3 system. T 3 plays a central role in vertebrate development, growth, and metabolism (12) (13) (14) (15) (16) (17) (18) . The effects of EDCs on T 3 signaling will undoubtedly pose a threat to human and wildlife health (19 -22) . Keyed by the discovery of nuclear T 3 receptors (TRs) that function as transcription factors, recent advances have been made in examining the mechanisms of T 3 action at the molecular level (12, 13, 15, (23) (24) (25) (26) (27) (28) (29) (30) (31) . Concurrently, studies have also revealed a broad array of EDCs that can bind to TR and affect T 3 -regulated gene expression in vitro (32) . However, the lack of a suitable in vivo model to study EDCs' effects on TR function in vertebrate development impedes our understanding on whether and how persistent exposure to these bioaccumulative compounds affects human health.
One such compound is bisphenol A (BPA), an established EDC of the reproductive system. BPA is used in the production of plastics and has widespread applicability, making its manufacturing and processing an important economical factor as well as a source of BPA release into the environment (33) (34) (35) (36) (37) (38) (39) (40) . BPA studies have primarily focused on its estrogenic activity (4, 41) . Recently based on extensive review of the existing data, the National Toxicology Program of the National Institutes of Health raised concerns for neural and behavioral effects of BPA in fetuses, infants, and children at the currently allowed human exposures (www.niehs.nih.gov/news/media/questions/sya-bpa. cfm#2). The concerns from this reviewing panel were primarily focused on the estrogenic effects of BPA, even though the role of estrogens on mammalian neural development is unclear. On the other hand, neural and behavioral development is dependent on T 3 , raising the possibility that the developmental effects of BPA in humans may be manifested through the T 3 pathway. Given the possible cross talks between the T 3 and estrogenic pathways (42, 43) , BPA may indirectly affect T 3 signaling by influencing estrogenic pathways. On the other hand, in vitro studies have shown that BPA can bind to and antagonize T 3 activation of TR (44) , and a study using cultured mouse oligodendrocyte precursor cells found that BPA inhibited T 3 -induced differentiation (45) . In addition, a study with rats showed that BPA exposure during development produced an endocrine profile similar to that observed in patients with T 3 resistance syndrome (46) .
The ability of BPA to bind to both estrogen and thyroid receptors to elicit disruption makes it very difficult to study the actions of BPA during mammalian development. Suitable alternative in vivo models are urgently needed to evaluate the effects of BPA on T 3 function during development. Amphibian metamorphosis represents an attractive model due to its absolute dependence on T 3 but not estrogens (14, 15) , although sex steroids can alter larval development in amphibians (47) (48) (49) . Recent studies have shown that BPA blocks metamorphosis and affects T 3 -signaling in amphibians (50 -53) . In addition, it has been shown that BPA suppresses TRH-induced release of thyroidstimulating hormone and prolactin in adult bullfrog pituitary cells, suggesting that BPA can disrupt the hypothalamic-pituitary-thyroid axis (54) . On the other hand, BPA has also been shown to induce feminization in Xenopus laevis tadpoles (55, 56) , although a different study failed to produce this effect (57) .
Here we propose the use of X. laevis metamorphosis as a model to investigate whether and how BPA affects T 3 -dependent vertebrate development. To date, little molecular analyses have been carried out to determine how BPA affects either metamorphosis or other postembryonic developmental processes in vertebrates. Because changes in gene expression often precede morphological changes, we aimed to use microarray technology to determine the signaling transduction pathways underlying any metamorphic effects of BPA. We chose the intestine as the model system because it represents an organ that persists throughout metamorphosis but undergoes extensive but well-characterized remodeling (58, 59) . It is important to note that gene regulation by T 3 through TR is not only necessary but also sufficient for intestinal remodeling and other metamorphic processes (60) . Furthermore, because the metamorphic process can easily be manipulated by controlling the availability of T 3 via the tadpole rearing water, the influence of maternal hormones and the difficulty to manipulate the uterus-enclosed mammalian embryo are avoided.
Our molecular analysis indicates that BPA, even though mainly known as an estrogenic compound, predominantly disrupts T 3 -signaling pathways during metamorphosis, resulting in delayed metamorphosis. Our results suggest that similar adverse effects of BPA on human development by disrupting T 3 pathways is likely and argue for the importance of studying endocrine disruption in the developmental context in vivo. They also highlight the power of combining morphological and molecular analyses of amphibian metamorphosis for studying endocrine disruption in development.
Materials and Methods

Animals
Tadpoles of X. laevis used in this study were purchased from NASCO (Fort Atkinson, WI). The animals were exposed to a 12-h light, 12-h dark photoperiod (lights on at 0700 h) and were fed spirulina, a fresh water alga, at 1000 h. Animal studies were approved by National Institute of Child Health and Human Development Animal Use and Care Committee.
Chemicals
T 3 , BPA, and dimethyl sulfoxide (DMSO) were purchased from Sigma (St. Louis. MO). All exposure treatments were conducted in 0.1% DMSO solution.
Oocyte injections and luciferase assays
Microinjection experiments were performed as described (61, 62) . Briefly, a reporter construct, TRE-Luc, harboring the T 3 -dependent X. laevis TR␤A promoter driving the firefly luciferase reporter was microinjected (0.33 ng/oocyte) into the nuclei of X. laevis oocytes together with a plasmid harboring the control Renilla luciferase reporter. In vitrotranscribed mRNAs encoding TR␤ and retinoid X receptor (RXR)-␣ were coinjected (1.15 ng/oocyte for TR␤ and RXR␣) into the cytoplasm. After overnight incubation in the presence or absence of BPA and/or T 3 , oocytes were assayed for luciferase activity.
Animal exposures to BPA
Experiment 1
BPA exposures were performed in a static-renewal system based on previous studies (51, 52, 56) . Before exposure, test animals were acclimatized to laboratory conditions at 23-24 C for 24 h. During the acclimatization and exposure periods, the animals were not fed to eliminate dietary influence on metamorphosis progression (note that tadpoles undergoing metamorphosis or T 3 treatment do not feed) (15) . Ten premetamorphic X. laevis tadpoles (stage 54) were randomly transferred into 1-liter tanks containing dechlorinated water. Animals were subsequently exposed to conditions with 2 nM T 3 , 0.1 or 10 M BPA, or the combination of 2 nM T 3 and 0.1 or 10 M BPA; the corresponding control group contained DMSO vehicle. The two concentrations of BPA used in this study are known to interfere with T 3 action in vitro (44) and physiologically relevant for human infants (0 -12 months) (within 24 h, estimated infant intake is 13 g/kg body weight or 60 nM, calculated based on the assumption that: 1) BPA uptake is equivalent to BPA metabolized and excreted by the body within the 24 h and 2) BPA is equally distributed throughout the body with a density of 1; the Environmental Protection Agency has set safe level of exposure to 50 g/kg per day in the United States) (www.niehs.nih.gov/news/media/questions/sya-bpa.cfm#2). Exposure treatment was conducted for 21 d at 23-24 C under 12-h light, 12-h dark cycle conditions. Water changes and chemical replacement were performed every other day. The developmental stages of the animals from each group were examined every 3 d. During the experiments, tadpoles were anesthetized in 0.02% 3-aminobenzoic acid ethyl ester (Sigma) and photographed under a stereomicroscope (Olympus, Tokyo, Japan) for gross morphology analysis. Each treatment was repeated at least three times (10 tadpoles/replicate) using tadpoles derived from different sets of adults.
Experiment 2
To study the effect of BPA on T 3 -induced gene expression during development, a short-term exposure experiment was performed. Acclimatization and exposure conditions were performed as described above. Groups of 10 premetamorphic X. laevis tadpoles (stage 54) were randomly placed into four tanks with 1 liter of dechlorinated water. Animals were subsequently exposed to conditions with the DMSO vehicle, 2 nM T 3 , 10 M BPA, or the combination of 2 nM T 3 and 10 M BPA. Exposure treatment was conducted for 4 d at 23-24 C under 12-h light, 12-h dark cycle conditions. Water changes and chemical replacement were performed after 2 d of exposure. Each treatment was replicated three times (10 tadpoles/replicate).
RNA isolation and microarray analysis
At the end of the 4-d treatment period, the intestine from 10 tadpoles were isolated and pooled for each of the three biological replicates per treatment. RNA was isolated and subjected to cDNA array (slides AMADID 013665; Agilent, Santa Clara, CA) analysis by using a two-color reference design system as described (63, 64) (also see supplemental Fig. S1 , published as supplemental data on The Endocrine Society's Journals Online web site at http://endo.endojournals.org). To identify significantly regulated genes, we performed ANOVA across all treatments and used a false discovery rate of 10% or less for multivariate correction (65-67).
Real-time PCR quantification
This was performed as described (63) using the three RNA samples as in the microarray as well as another from other tadpoles treated under the same conditions to confirm the microarray data. Real-time quantitative RT-PCR (qRT-PCR) was carried out using FAM-labeled Taqman probes for some genes (supplemental Table S1 ) with cDNA standards made from whole-body total RNA from tadpoles at stages 50 -66. The expression level of each gene was normalized to that of the control gene, ribosomal protein L8 (rpl8). Additional genes were analyzed with SYBR Green I dye (supplemental Table S2) , and the expression level of each gene was normalized to that of the control gene, elongation factor-1␣ (EF-1␣). In a preliminary experiment, we observed that the levels of rpl8 and EF1␣ were not different in intestine samples from control and chemically treated tadpoles. For data analysis, intergroup comparisons were performed with ANOVA followed by Fisher's protected least significant difference test; P Յ 0.05 was considered to be statistically significant.
Histology
The intestines were dissected, flushed and fixed in Bouin's fluid for 24 h, rinsed in 0.6ϫ PBS and stored in 70% ethanol. Paraffin embedded FIG. 1. BPA inhibits TR-mediated transcription and T 3 -induced metamorphosis. A, The mRNAs for TR/RXR (1.15 ng/oocyte) were injected into the cytoplasm of 20 oocytes as indicated. After 4 h of incubation, the TRELuc reporter vector (TRE) together with the control Renilla luciferase plasmid were coinjected into the nucleus of the oocytes. The oocytes were incubated overnight with or without T 3 (2 nM) and indicated amounts of BPA. After incubation, the oocytes were lysed and subjected to dual-luciferase assays. The relative activity of the reporter vs. that of the control was plotted with the basal luciferase activity set to 1 (lane 1, in the absence of T 3 ). The bars represent the means Ϯ SE of at least two independent experiments performed in quadruplicates. *, P Յ 0.05 vs. lane 4 in the presence of T 3 . Insert, Structural comparison of BPA (upper panel) and T 3 (lower panel). B, Dose-and time-dependent inhibition of T 3 -induced X. laevis metamorphosis by BPA. The average developmental stages of the animals were plotted every third day, and each point represents the mean Ϯ SE. An asterisk indicates significant differences in the development stages between T 3 and T 3 ϩBPA treatment groups (P Յ 0.05). Note only one time point for one treatment group did not show a statistically significant difference in development progression compared with T 3 -treated animals (d 6; 10 M BPAϩT 3 ). There was no significant difference in development between control (DMSO vehicle control) and BPA-only-treated animals. C, Representative profile of tadpoles housed in water (DMSO vehicle control), T 3 (2 nM), BPA (0.1 or 10 M), or combinations of BPA (0.1 or 10 M) and T 3 (2 nM). Groups of 10 tadpoles at stage 54 (d 0) were used for each treatment. Tadpoles representing the typical stage in each treatment were photographed and the gross morphology observed for 9-and 21-d-treated tadpoles are presented here.
5-m-thick sections were serially collected on glass slides and stained with hematoxylin-eosin.
Results
BPA suppresses T 3 -induced transcription
BPA is known to bind to and antagonize T 3 -dependent activation of mammalian TR (44) . To investigate whether BPA influences X. laevis TR in vivo, we analyzed the effect of BPA on TR-dependent luciferase reporter (TRE-Luc) expression in the reconstituted frog oocyte system, a model to study T 3 -mediated transcription in the context of chromatin (61) . In the absence of T 3 , overexpressed TR␤ and RXR␣ repressed the promoter, as reported (62, 68) , whereas in the presence of T 3 , the promoter was activated (Fig. 1A) . BPA inhibited the transcriptional activation of the promoter by T 3 but had little effect on the promoter in the absence of T 3 (Fig. 1A) . In the absence of TR␤ and RXR␣, BPA had no significant effect on the promoter activity (data not shown). Thus, BPA may function as an inhibitor of gene activation by T 3 to affect X. laevis development.
BPA inhibits T 3 -induced metamorphosis
To study the effect of BPA on development, premetamorphic tadpoles were treated with BPA, T 3 , or a combination of both (Fig. 1, B and C). Gross morphology was monitored to determine the developmental stages every 3 d for a 21-d study period. Treatments of premetamorphic tadpoles with T 3 resulted in well-established morphological changes (15) , and the inhibition of these changes by BPA could be observed as early as 3 d (Fig. 1B and  supplemental Fig. S2 ). At the end of the 21-d study, T 3 -treated animals had metamorphosed to stage 64, whereas the control animals reached only stage 56 (Fig. 1C) . No significant stage difference was observed between control (DMSO) and BPAtreated animals. The tadpoles that were exposed to combined T 3 and BPA (T 3 ϩBPA) were significantly delayed in metamorphosis compared with the T 3 -treated animals, and this effect of BPA was dose dependent (Fig. 1B) .
To study the effect of BPA on the remodeling of visceral organs during development, we analyzed the intestine, a model organ that has been well characterized morphologically and molecularly (58, 59, 63, 69) . After 4 d of treatment, control intestinal cross-sections had thin muscle layers around the exterior, a thin layer of connective tissue, and a simple inner epithelium with a single in-folding, the typhlosole, which contains the majority of connective tissue in the larval intestine ( Fig. 2A) . Little morphological change occurred after 4 d of BPA treatment, and these intestinal samples were comparable with those of the untreated samples (Fig. 2B) . In the presence of T 3 , the overall length of the intestine shortened (data not shown). Histological examination of the T 3 -treated intestine revealed the well-documented tissue remodeling responses to T 3 , such as the increased thickness in muscle and connective tissue layers (Fig. 2C) (59) . In the presence of T 3 ϩBPA, very little morphological change occurred (Fig. 2D) .
BPA inhibits T 3 -induced gene expression
To investigate whether BPA inhibits the expression of T 3 -response genes, we first determined whether known T 3 response genes were affected by BPA. Total RNA was isolated from the intestine and qRT-PCR was performed. The expression of three early, direct T 3 response genes, TR␤, stromelysin-3 (ST3), and T 3 -responsive basic leucine zipper transcription factor (TH/ bZIP) was significantly higher in the T 3 -treated tadpoles than the control or BPA-treated counterparts after 4 d (Fig. 3A) . The expression level of ST3 and TH/bZIP were significantly reduced in the combined T 3 ϩBPA group compared with the T 3 -only group, although BPA had little effect on the T 3 induction of TR␤. The expression of two late, likely indirect T 3 response genes, matrix metalloproteinase (MMP)-2 and the tissue inhibitor of metalloproteinase (TIMP)-2, were also significantly reduced in the T 3 ϩBPA-treated animals compared with the T 3 -treated animals. The expression of the third late response gene, bone morphogenetic protein (BMP)-4, in the T 3 ϩBPA-treated group was not significantly different from either the T 3 -treated or control group, although there was significant difference between the control and T 3 -treated groups (Fig. 3B) . (Note that because different T 3 response genes have different T 3 regulation kinetics, it is possible that TR␤ and BMP4 are affected by BPA at different time points). These results suggest that BPA inhibits the expression of known T 3 -response genes. 
BPA predominantly affects T 3 -signaling pathways in the intestine
To investigate whether BPA indeed inhibits T 3 -induced metamorphosis by blocking the T 3 -signaling pathways, we performed a genome-wide analysis by profiling gene expression in the intestine with a 60-mer oligonucleotide microarray (cDNA array). Because the phenotypes of BPA exposed tadpoles were similar with BPA at either concentration and reproducible, we performed the subsequent molecular analysis at the higher dose to detect the relatively small changes in gene expression caused by BPA. Total RNA was isolated from the intestine of tadpoles treated for 4 d with control solution (DMSO), BPA (10 M), T 3 (2 nM), and combined T 3 (2 nM) ϩ BPA (10 M). For cDNA array analysis, we used a two-color labeling system, with Cy3-labeled experimental sample and Cy5-labeled universal control made of RNA isolated from whole animals of different metamorphic stages as the internal reference (supplemental Fig. S1 ). For each treatment group, three biological replicates, each consisting of 10 pooled intestine samples, were used. Quality control of the data were performed as previously described (63) .
To identify significantly regulated genes, we performed ANOVA across all treatment groups with statistical significance of 10% false discovery rate with the fold change cutoff value set at 1.1 or greater for the regulated genes. Note that a relatively low cutoff was chosen because the effect of BPA on gene regulation was expectedly small. Because of the reproducibility of the cDNA array and the use of three biological replicates/treatment, it was possible to obtain statistically significant changes at this fold change cutoff. Of the 21,654 genes represented on the microarray, we found 1874 significantly regulated genes. There were 1051 and 728 genes significantly up-and down-regulated, respectively, in the T 3 -treated intestines compared with the controls (Fig. 4, A and B, respectively; supplemental Tables 3 and S4 , respectively). Many of the genes that were differentially regulated by T 3 after 4 d were similar to those reported previously (63) (data not shown). The gene regulation profiles of the T 3 and combined T 3 ϩBPA samples were remarkably similar. The highest number of shared regulated genes was recorded between these two groups, in which 716 and 567 genes were exclusively shared up-and down-regulated, respectively (Fig. 4, A and B , respectively). There were 293 up-regulated genes common to all three treatments (BPA, T 3 , and combined T 3 ϩBPA) and 120 common down-regulated genes. Of the total number of regulated genes on the array, 211 of these genes were exclusively up-regulated and 168 of these genes were exclusively down-regulated in the BPAonly-treated group (supplemental Tables S5 and S6 , respectively), suggesting that BPA can affect genes independent of the T 3 pathway during development.
Given the inhibitory effects of BPA on all aspects of T 3 -induced metamorphosis, it seemed surprising that most of the upor down-regulated genes in the T 3 group were also similarly affected in the T 3 ϩBPA-treated group in comparison with the controls (Fig. 4) . However, as shown above, BPA only partially blocked the regulation of established T 3 -response genes (Fig. 3) . Thus, it is likely that BPA may globally attenuate the magnitude of T 3 -regulation to inhibit metamorphosis. To test this, we analyzed the microarray data and compared the expression levels of individual genes between T 3 -and T 3 ϩBPA-treated groups to identify T 3 -dependent genes whose expression was affected by the presence of BPA. Of the 21,654 genes on the microarray, 342 genes had decreased expression in the presence of BPA in the T 3 -treated intestines compared with T 3 -only-treated animals (supplemental Table S7 ). Among these BPA down-regulated transcripts, most (62%) of these genes were identified as T 3 -induced genes (compared with vehicle treated control), revealing an attenuation of T 3 -dependent gene activation by BPA (Fig.  5A) . The remaining down-regulated genes in the T 3 ϩBPA treatment group relative to T 3 alone could be subdivided into genes known to be down-regulated by T 3 (when compared with vehicle treated control) whose expression was now, in the presence of BPA, further repressed (22%) and genes whose expression did not have any known T 3 dependency (16%). To validate the repression of the T 3 -induced genes by BPA, 10 of the genes were analyzed by qRT-PCR across all treatment groups with total RNA isolated independently from that used in the microarray. The BPA regulation of all selected genes was confirmed by qRT-PCR, of which nine are represented here (Fig. 5B) .
In the presence of BPAϩT 3 , 159 genes had enhanced expression when compared with T 3 treatment alone (supplemental Table S8). Of these genes, 48% were down-regulated in the presence of T 3 (when compared with vehicle treated control),
FIG. 3.
The relative expression of known T 3 -inducible genes was reduced in the intestine of animals exposed to BPA. The cDNA was generated from total RNA of tadpoles treated as in Fig. 2 and subjected to qRT-PCR. A, Direct T 3 -response genes ST3, TH/bZIP, and TR␤ were examined. B, Late T 3 -response genes MMP-2, TIMP2, and BMP4 were examined. The results are expressed as fold induction of the transcript with respect to the control gene, rpl8. The expected increase in relative levels of transcript with respect to rpl8 was observed in the presence of T 3 . For graphical presentation, results were expressed as fold induction as compared with the DMSO vehicle control. Data are shown as means Ϯ SE (n ϭ 3; pooled samples of 10 intestines for each treatment). In the animals treated with T 3 ϩBPA, the expression levels of ST3, TH/bZIP, MMP-2, and TIMP2 genes were significantly reduced in the intestine. An asterisk indicates significant differences in mRNA expression levels between T 3 and T 3 ϩBPA treatment groups (P Յ 0.05).
revealing an abrogation of T 3 -dependent gene repression by BPA (Fig. 5C ). The remaining genes showing enhanced expression in the T 3 ϩBPA treatment group relative to T 3 alone, included genes known to be up-regulated by T 3 (when compared with vehicle treated control), which now in the presence of BPA were further enhanced (47%), and genes that did not have any known T 3 dependency (5%). Again, qRT-PCR was used to confirm the regulation of T 3 -response genes by BPA as found by the cDNA array. Here four genes were analyzed by qRT-PCR, and their regulation by BPA was confirmed (Fig. 5D) .
The above qRT-PCR results thus confirmed the findings from microarray analysis. More importantly, the microarray results demonstrate that BPA functions mainly by inhibiting T 3 -pathways because most of the BPA-affected genes were T 3 -response genes whose regulation by T 3 was attenuated by BPA.
The antimetamorphic effects of BPA are associated with inhibition of T 3 -dependent gene regulation programs
Whereas the major effects of BPA is the inhibition of T 3 signaling pathways, it is possible that the antimetamorphic effects of BPA may be due to effects of BPA on genes independent of T 3 . Thus, we analyzed the genes that were regulated by T 3 after 4 d of treatment. Of the total number of T 3 up-regulated genes (1051), 33% of these genes were down-regulated by BPA (data not shown). Conversely, of the total number of T 3 down-regulated genes (728), 36% of these genes were up-regulated by BPA (data not shown). Interestingly, when we ranked the T 3 -induced genes from most dramatically regulated to the least regulated, we found that the majority of the 50 most dramatically T 3 up-regulated genes (Ն2.5-fold induction by T 3 ) were inhibited by BPA (Fig. 6A) . Similarly, the T 3 repression of most of the 50 dramatically T 3 down-regulated genes (Ն1.9-fold repression by T 3 ) was reduced/abrogated by BPA (Fig. 6B) . Moreover, by incorporating microarray data of T 3 -responsive genes in the tail, hindlimb, and brain (64), we observed that the vast majority of these dramatically regulated genes that are also induced by T 3 in other organs were inhibited by BPA in the presence of T 3 (Fig. 6A) . Conversely, of the 12 genes that are known to be down-regulated by T 3 in multiple organs, T 3 repression of seven genes was abrogated by BPA (Fig. 6B) . These results suggest that BPA inhibits most of the genes highly up-regulated by T 3 . The reason for our failure to detect BPA inhibition of genes less significantly up-regulated by T 3 was most likely because their regulation by T 3 was approaching the lower limit of the cDNA array analysis, thus making the regulation by BPA fall below the detection limit. Because gene regulation by T 3 -bound TR is both necessary and sufficient for amphibian metamorphosis, these results suggest that BPA inhibits metamorphosis because it blocks most of the T 3 -signaling pathways.
Discussion
In the present study, we characterized for the first time global gene expression changes associated with BPA exposure by using amphibian metamorphosis as our experimental model. This model was favorable over mammalian models because the in vivo screening process was quicker and the influence of maternal hormones and the difficulty in manipulating the uterus-enclosed embryo were eliminated. Whereas BPA was able to regulate many genes in premetamorphic tadpoles in the absence of T 3 , there was no detectible morphologic phenotype, making it difficult to determine the significance. We thus focused our analysis on the effect of BPA during metamorphosis, i.e. when T 3 is also present. Our microarray analysis revealed novel findings. First, BPA inhibited the regulation of most T 3 -dependent responsive genes, which presumably underlie the inhibition of metamorphosis by BPA, which was not evident from limited analyses in earlier studies. Second and more importantly, BPA predominantly affected T 3 -signaling pathways during metamorphosis, although the influence of BPA on estrogen-signaling pathways in metamorphosing tadpoles cannot be dismissed. Our findings thus point to the critical need, even for EDCs of known effects, to have suitable developmental models to analyze the potential effects of EDCs on human embryonic and postembryonic development.
Of the two BPA concentrations used in this study, the lower concentration (0.1 M) closely resembled the estimated BPA exposure level in human infants (see Materials and Methods). Both doses inhibited TR␤-induced transcription in the frog oocyte system. Furthermore, whereas the two doses ranged 100-fold, both inhibited T 3 -induced metamorphosis reproducibly with the higher dose resulting in a more dramatic inhibition. These findings are in strong support that BPA acts as a T 3 antagonist in vivo.
FIG. 4.
Venn diagrams showing the number of up-and down-regulated genes for the treatment groups in comparison with that of the control group. A, A total of 1317 genes were up-regulated in response to treatment with the exogenous compounds, T 3 and/or BPA. There were 293 genes commonly up-regulated in all three treatment groups, and 39, 211, and 55 genes were up-regulated only in treatment groups for T 3 , BPA, or T 3 ϩBPA, respectively. There were 716 genes commonly up-regulated between T 3 and T 3 ϩBPA groups, three genes between T 3 -and BPA-only groups, and none between BPA and T 3 ϩBPA groups. B, A total number of 947 genes were down-regulated in response to treatment with the exogenous compounds, T 3 and/or BPA. There were 120 genes commonly down-regulated in all three treatment groups, and 41, 168, and 49 genes were down-regulated only in treatment groups for T 3 , BPA, or T 3 ϩBPA, respectively. There were 567 genes commonly down-regulated between T 3 and T 3 ϩBPA groups, no genes between T 3 -and BPA-only groups, and two genes between BPA and T 3 ϩBPA groups.
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Given that high levels of T 3 are critical for human development, especially during the late-embryonic and neonatal period that share many similarities with frog metamorphosis (12-14, 17, 19, 70, 71) , our results argue that BPA represents a serious risk to human development through disruption of T 3 signaling pathways. Using microarray, we found that after 4 d of treatment, the regulation of about 33% of the T 3 -induced genes and 36% of the T 3 -repressed genes were inhibited by BPA. Interestingly, the majority of the most dramatically T 3 -regulated genes were affected in the presence of BPA. Many of these genes are early and/or direct target genes of T 3 and are likely important for metamorphosis. For example, ST3 is a direct T 3 target gene and has been shown to be necessary for apoptosis and tissue morphogenesis during intestinal metamorphosis (72, 73) . Thus, its inhibition by BPA may contribute to the blockage of intestinal remodeling during metamorphosis by BPA. In addition, most of these BPAaffected T 3 -response genes are ubiquitously regulated by T 3 in different organs as suggested by our metatissue analysis. All these and the fact that gene regulation by T 3 -bound TR is necessary and sufficient for amphibian development (60, 74) strongly argue that the BPA inhibition of these most dramatically T 3 -regulated genes, including ST3, is the underlying cause for the in-FIG. 5. Analysis and verification of genes newly identified by the microarray, whose expression was disrupted by BPA in the presence of T 3 . A, When the gene expression levels in the T 3 -treated group were compared with those in the T 3 ϩBPA-treated group, expression levels of 342 genes were reduced in the presence of BPA, most of which (60%) were T 3 -induced genes (i.e. their expression was up-regulated by T 3 when compared with the control, untreated group). B, Verification of BPA regulation of T 3 -induced genes whose T 3 induction was reduced by BPA. All up-regulated T 3 genes tested by qRT-PCR showed that in the presence of BPA, the expression levels were reduced, confirming the findings from the microarray. C, When the gene expression levels in the T 3 -treated group were compared with those in the T 3 ϩBPA-treated group, the expression of 159 genes was increased by BPA, of which 48% were genes that were down-regulated by T 3 (when compared with the control, untreated group) and had their down-regulation abrogated by BPA. D, Verification of BPA regulation of T 3 -regulated genes whose down-regulation was abrogated by the presence of BPA. All four T 3 -downregulated genes tested by qRT-PCR showed that in the presence of BPA, their expression levels were partially reversed as observed by the microarray. For graphical presentation, the qRT-PCR results were expressed as fold induction as compared with the DMSO vehicle controls (control ϭ 1), after normalization with the housekeeping gene, EF1␣. Data are shown as means Ϯ SE (n ϭ 3; pooled samples of 10 intestines for each treatment). An asterisk indicates significant differences in mRNA expression levels between T 3 and T 3 ϩBPA treatment groups (P Յ 0.05). GenBank accession numbers are shown above each chart.
2970
Heimeier et al. hibition of metamorphosis by BPA. The failure to observe significant effects by BPA on many less dramatically regulated T 3 -response genes is presumably due to the difficulty to detect the relatively small changes in their expression caused by BPA with microarray analysis. Whereas one may expect that BPA inhibit metamorphosis by disrupting T 3 signaling, it is surprising that the vast majority of the genes affected by BPA are T 3 -response genes. Of the BPA down-regulated genes in the presence of T 3 , 60% were T 3 -induced genes whose activation by T 3 was now reduced/eliminated by BPA. Conversely, about 50% of the BPA up-regulated genes in the presence of T 3 were T 3 -down-regulated genes whose down-regulation by T 3 was reduced/eliminated by BPA. Only about 20% of the BPA-regulated genes in the presence of T 3 were completely independent of T 3 -signaling process. Our studies thus indicate that developmental context has a major role in determining the pathways by which BPA interacts in vivo. In this regard, it is worth noting that T 3 , but not other hormones, is the causative agent of amphibian metamorphosis and hence intestinal remodeling (15) . Whereas it is possible that potential cross talks between TR and estrogen receptor (ER)-signaling pathways (42, 43, 75) may allow BPA to affect T 3 -pathway through ER, the fact that most of the BPA regulated genes are T 3 -response genes argue against this. In addition, as discussed above, most of the dramatically T 3 -regulated genes are affected by BPA, suggesting that BPA is likely targeting TRs directly during metamorphosis. Currently there are no data on the expression profiles of estrogens and ER␣ in the intestine during development, although ER␣ mRNA could be detected in whole-body premetamorphic tadpoles and were up-regulated after prolonged T 3 treatment in the liver (76) (77) (78) . Our microarray analysis showed no regulation by BPA in the expression of two known estrogen-response genes, ER␣ (AY310905, L20736) and steroid-5-␣-reductase (BQ732157) (76, 79) , from BPA or combined T 3 ϩBPA treatments. Furthermore, treatment with T 3 alone did not change their gene expression, suggesting that there does not appear to be any cross-regulation between estrogens and T 3 in the metamorphic intestine. It is possible that the lack of significant ER in the tadpole intestine may be the underlying cause for the observed dominant effects of BPA on T 3 -signaling process during metamorphosis in this study.
In summary, our findings demonstrate that BPA, which is one of the most prevalent chemicals for daily use, suppresses transcriptional activity of ligand-bound TR during vertebrate development. Moreover, genome-wide analysis leads to two major conclusions. First, the inhibitory effect of BPA on metamorphosis is due to the inhibition of the T 3 pathway. Endocrine disruptor studies normally focus on the regulation of one or a few genes; the pathways involving these genes may or may not have any endo.endojournals.orgsignificant contribution to the biological effects of the disruptor. This argues for genome-wide molecular analysis of the effect of endocrine disruptors. Second, the major effect of BPA in developing tadpoles is on the T 3 , but not estrogenic pathways, which would be expected based on previous BPA studies in vitro and in adult animals, although estrogenic pathways are also likely to be affected by BPA. This argues that the effects of an endocrine disruptor are tissue and developmental stage dependent and that in vivo studies coupled with genome-wide molecular gene regulation analysis are needed to assess the biological effects of an endocrine disruptor and the underlying molecular mechanism. Our findings further demonstrate the unique advantages of combining morphological analysis with genome-wide gene expression studies in amphibians to determine the molecular pathways that underlie a developmental consequence of an EDC, especially for those affecting T 3 pathways. The diverse array of EDCs that may disrupt T 3 levels and the potential for concurrent exposure to many of these compounds make it imperative to use in vivo developmental models to appreciate the effects of EDCs on vertebrate development. This will help to ensure that important environmental health and developmental consequences of EDC exposure are not overlooked.
